Table 2.
Cell Line | IC50 mix (μg/mL) | n mix | L IC50 add (μg/mL) | n add | U IC50 add (μg/mL) | n add | p-Value | Type of Interaction |
---|---|---|---|---|---|---|---|---|
MCF7 | 32.483 ± 1.508 | 90 | 4.314 ± 3.781 | 140 | 17.573 ± 4.743 | 140 | 0.0032 ** | antagonism |
T47D | 19.112 ± 3.055 | 90 | 3.478 ± 2.515 | 140 | 14.158 ± 3.404 | 140 | 0.2799 | tendency towards antagonism |
MDA-MB-231 | 21.352 ± 1.980 | 72 | 3.638 ± 2.840 | 158 | 11.304 ± 3.813 | 158 | 0.0203 * | antagonism |
MDA-MB-468 | 15.713 ± 1.513 | 90 | 3.671 ± 2.391 | 158 | 12.927 ± 3.155 | 158 | 0.4268 | tendency towards antagonism |
nmix—total number of items used at those concentrations whose expected anti-proliferative effects ranged between 16% and 84% (i.e., 4 and 6 probits) for the experimental mixture; n add—total number of items calculated for the additive mixture of the drugs examined; L—IC50 add value calculated from the equation for the lower line of additivity; U—IC50 add value calculated from the equation for the upper line of additivity. Statistical evaluation of data was performed with unpaired t-test with Welch’s correction. * p < 0.05 and ** p < 0.01 vs. the respective IC50 mix value.